Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Blepharitis: full-pipeline trial registry
1 of 7 indexed Blepharitis trials are currently recruiting.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 1 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Blepharitis: 7 US clinical trials tracked, 1 recruiting.
Blepharitis is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is John, George, M.D., running 1 of these trials.
Enrollment posture brief
Registry condition blepharitis
OPEN 1 | RECR 14% | LATE 3 | EARLY 2 | RANK #2497 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adverse Drug Events (14% recruiting · 7 trials)
Blepharitis lists 1 open slots (14% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Blepharitis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Blepharitis is recruiting below its size-band peers.
1 of 7 indexed trials (14.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Blepharitis trials is spread across many organizations.
John, George, M.D. accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.
-
Most Blepharitis trials plan to enrol fewer than 100 people.
Median target enrolment is 36 among the 7 trials that report a genuine target (sentinel values excluded). 6 of those (85.7%) plan for fewer than 100 participants.
-
Blepharitis research is mostly interventional.
7 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
Evaluation of SUMMIT BRUSH in Treatment of Blepharitis
University of Notre Dame
NCT04603222
Effect of an Exploratory Vehicle on Meibomian Gland Dysfunction in Patients With Demodex
Tarsus Pharmaceuticals
NCT06054217
A Study to Evaluate the Clinical Efficacy and Safety of Tobradex® ST Compared to Azasite® in the Treatment of Subjects With Moderate to Severe Chronic Blepharitis
Alcon Research
NCT01102244
Treatment of Patients With Blepharitis and Facial Rosacea
Galderma R&D
NCT00560703
Comparative Study in the Efficacy of Topical Besifloxocin With Erythromycin for the Management of Acute Blepharitis
John, George, M.D.
NCT01478256
Safety and Efficacy Study of AzaSite® in Subjects With Blepharitis
Merck Sharp & Dohme
NCT00629941
Corneal Epithelial Stem Cells and Dry Eye Disease
Sloan W. Rush, MD
NCT03302273
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 1 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Blepharitis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Blepharitis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Blepharitis page
7 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Blepharitis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- John, George, M.D. sponsors the most Blepharitis trials on record, review their full trial history before evaluating a specific study. See John, George, M.D.'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Blepharitis condition card totals 7 registered trials; most-linked intervention COL-101 (doxycycline, USP) capsules; top US site state Kentucky. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.